Gene Expression Data From New Analysis Method Supports That a Larger Proportion of Patients will Benefit From Arfolitixorin
- Monday, March 30, 2020, 7:11
- PR Newswire
- Add a comment
GOTHENBURG, Sweden, March 30, 2020 /PRNewswire/ — Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today announced that new gene expression data based on a validated method from TATAA Biocenter AB, which is significantly more sensitive than the pre-commercial…
About the Author
admin has written 20720 stories on this site.